Results 141 to 150 of about 26,023 (245)

Intravenous apomorphine therapy in Parkinson's disease: Clinical and pharmacokinetic observations [PDF]

, 2001
Alice J. Manson
openalex   +1 more source

Auto-oxidation of Apomorphine

, 1961
Pushkar N. Kaul, E. Brochmann‐Hanssen
openalex   +1 more source

Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment

, 2003
Lorenzo Priano, Giovanni Albani, Andrea Brioschi, Giulia Guastamacchia, Sara Calderoni, Leonardo Lopiano, Mario Giorgio Rizzone, Roberta Cavalli, Maria Rosa Gasco, F. Fraschini, B. Bergamasco, Alessandro Mauro   +11 more
openalex   +2 more sources

Iatrogenic hemoperitoneum and sigmoid colon injury from malpositioned apomorphine infusion device in advanced Parkinson's disease. [PDF]

Radiol Case Rep
Hughes C, Fazio T, Umstad C.
europepmc   +1 more source

Suppression of tumor cell growth and mitogen response by aporphine alkaloids, dicentrine, glaucine, corydine, and apomorphine.

, 1990
Y Konda, Yoshihiro Imai, Hiroshi Hojo, Takeshi Endo, Shigeo Nozoe   +4 more
openalex   +2 more sources

Comparison of motor response to apomorphine and levodopa in Parkinson's disease. [PDF]

, 1990
Peter Kempster, J P Frankel, G M Stern, Andrew J. Lees   +3 more
openalex   +1 more source

Apomorphine differentially engages the cAMP and β-arrestin signaling pathways relative to dopamine at human dopamine receptors. [PDF]

J Neural Transm (Vienna)
Yegla B, Rubin J, Grall M, Formella A, Jenner P.   +4 more
europepmc   +1 more source

Apomorphine Hydrochloride [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Stimulants for disorders of consciousness in the intensive care unit: a randomized, placebo-controlled trial. [PDF]

Brain
Othman MH, Toury-Puel AG, Hansen KIT, Amiri M, Zarifkar P, Peinkhofer C, Stückler SG, Olsen MH, Bjerregaard J, Smitt M, Magnussen AS, Forsse A, Møller J, Nielsen MKK, Jessen CH, Hassager C, Hyttel-Sørensen S, Perner A, Møller MH, Møller-Sørensen PH, Hauerberg J, Birkeland P, Sigurdsson ST, Wamberg CA, Itenov TS, Meyhoff CS, Møller K, Andersen TS, Kjaergaard J, Kondziella D.   +29 more
europepmc   +1 more source

Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study

Stuart Isaacson, Alberto J. Espay, Rajesh Pahwa, Pinky Agarwal, Holly A. Shill, Jennifer Hui, Khashayar Dashtipour, Mark Lew, Peibing Qin, Andrea E. Formella, Gianpiera Ceresoli‐Borroni, Peter A. LeWitt, on behalf of the InfusON Study Group   +12 more
openalex   +1 more source